Bhatia Sangeeta N. sold VRTX
May 4, 2026 · Form 4 insider transaction
Bhatia Sangeeta N. sold 318 shares of Vertex Pharmaceuticals Incorporated at $423.73 per share, a transaction worth $134.7K. The trade was recorded as open-market sale under a pre-scheduled Rule 10b5-1 plan and disclosed on an SEC Form 4, filed 1 day after the transaction.
Direction
Disposed (sell-side)
Shares
318
Price
$423.73
Total value
$134.7K
InsiderBhatia Sangeeta N.
Role—
SecurityCommon Stock
Transaction codeS: Open-market sale
Transaction dateMay 4, 2026
Filing dateMay 5, 2026
Shares owned after4,924
OwnershipDirect
10b5-1 planYes
AmendedNo
Footnotes
Transaction made pursuant to Dr. Bhatia's company approved trading plan under Rule 10b5-1, which was entered into on 05/27/2025.